Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
This randomized phase III trial studies how well Lactobacillus plantarum works in preventing acute graft versus host disease in children undergoing donor stem cell transplant. Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus host disease in children, adolescents, and young adults undergoing donor stem cell transplant.
Research Base: Children's Oncology Group
NCT ID: NCT03057054
NCI Protocol Number: COG-ACCL1633
Status: Active, not recruiting
For more information see ClinicalTrials.gov
Interventions
- Allogeneic Hematopoietic Stem Cell Transplantation
- Lactobacillus plantarum strain 299
- Lactobacillus plantarum strain 299v
- Placebo Administration
Condition
Hematopoietic and Lymphoid System Neoplasm, Leukemia, Lymphoma
Trial Type
Supportive Care/Symptom Management/PROs
See a list of participating sites on ClinicalTrials.gov